Literature DB >> 25544560

Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.

Madushi Raththagala1, M Kathryn Brewer1, Matthew W Parker1, Amanda R Sherwood1, Brian K Wong2, Simon Hsu2, Travis M Bridges1, Bradley C Paasch1, Lance M Hellman3, Satrio Husodo1, David A Meekins1, Adam O Taylor1, Benjamin D Turner1, Kyle D Auger1, Vikas V Dukhande1, Srinivas Chakravarthy4, Pascual Sanz5, Virgil L Woods2, Sheng Li2, Craig W Vander Kooi6, Matthew S Gentry7.   

Abstract

Glycogen is the major mammalian glucose storage cache and is critical for energy homeostasis. Glycogen synthesis in neurons must be tightly controlled due to neuronal sensitivity to perturbations in glycogen metabolism. Lafora disease (LD) is a fatal, congenital, neurodegenerative epilepsy. Mutations in the gene encoding the glycogen phosphatase laforin result in hyperphosphorylated glycogen that forms water-insoluble inclusions called Lafora bodies (LBs). LBs induce neuronal apoptosis and are the causative agent of LD. The mechanism of glycogen dephosphorylation by laforin and dysfunction in LD is unknown. We report the crystal structure of laforin bound to phosphoglucan product, revealing its unique integrated tertiary and quaternary structure. Structure-guided mutagenesis combined with biophysical and biochemical analyses reveal the basis for normal function of laforin in glycogen metabolism. Analyses of LD patient mutations define the mechanism by which subsets of mutations disrupt laforin function. These data provide fundamental insights connecting glycogen metabolism to neurodegenerative disease.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25544560      PMCID: PMC4337892          DOI: 10.1016/j.molcel.2014.11.020

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  52 in total

Review 1.  Protein tyrosine phosphatases: from genes, to function, to disease.

Authors:  Nicholas K Tonks
Journal:  Nat Rev Mol Cell Biol       Date:  2006-11       Impact factor: 94.444

2.  A novel protein tyrosine phosphatase gene is mutated in progressive myoclonus epilepsy of the Lafora type (EPM2).

Authors:  J M Serratosa; P Gómez-Garre; M E Gallardo; B Anta; D B de Bernabé; D Lindhout; P B Augustijn; C A Tassinari; R M Malafosse; M Topcu; D Grid; C Dravet; S F Berkovic; S R de Córdoba
Journal:  Hum Mol Genet       Date:  1999-02       Impact factor: 6.150

3.  Structural basis for the glucan phosphatase activity of Starch Excess4.

Authors:  Craig W Vander Kooi; Adam O Taylor; Rachel M Pace; David A Meekins; Hou-Fu Guo; Youngjun Kim; Matthew S Gentry
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

Review 4.  Glycogen and its metabolism: some new developments and old themes.

Authors:  Peter J Roach; Anna A Depaoli-Roach; Thomas D Hurley; Vincent S Tagliabracci
Journal:  Biochem J       Date:  2012-02-01       Impact factor: 3.857

5.  Phosphoglucan-bound structure of starch phosphatase Starch Excess4 reveals the mechanism for C6 specificity.

Authors:  David A Meekins; Madushi Raththagala; Satrio Husodo; Cory J White; Hou-Fu Guo; Oliver Kötting; Craig W Vander Kooi; Matthew S Gentry
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-05       Impact factor: 11.205

6.  STARCH-EXCESS4 is a laforin-like Phosphoglucan phosphatase required for starch degradation in Arabidopsis thaliana.

Authors:  Oliver Kötting; Diana Santelia; Christoph Edner; Simona Eicke; Tina Marthaler; Matthew S Gentry; Sylviane Comparot-Moss; Jychian Chen; Alison M Smith; Martin Steup; Gerhard Ritte; Samuel C Zeeman
Journal:  Plant Cell       Date:  2009-01-13       Impact factor: 11.277

Review 7.  Progressive myoclonus epilepsies: clinical and neurophysiological diagnosis.

Authors:  S F Berkovic; N K So; F Andermann
Journal:  J Clin Neurophysiol       Date:  1991-07       Impact factor: 2.177

8.  Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease.

Authors:  Felix Nitschke; Peixiang Wang; Peter Schmieder; Jean-Marie Girard; Donald E Awrey; Tony Wang; Johan Israelian; XiaoChu Zhao; Julie Turnbull; Matthias Heydenreich; Erich Kleinpeter; Martin Steup; Berge A Minassian
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

9.  Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.

Authors:  Vincent S Tagliabracci; Julie Turnbull; Wei Wang; Jean-Marie Girard; Xiaochu Zhao; Alexander V Skurat; Antonio V Delgado-Escueta; Berge A Minassian; Anna A Depaoli-Roach; Peter J Roach
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-26       Impact factor: 11.205

10.  Neurodegeneration and functional impairments associated with glycogen synthase accumulation in a mouse model of Lafora disease.

Authors:  Jordi Valles-Ortega; Jordi Duran; Mar Garcia-Rocha; Carles Bosch; Isabel Saez; Lluís Pujadas; Anna Serafin; Xavier Cañas; Eduardo Soriano; José M Delgado-García; Agnès Gruart; Joan J Guinovart
Journal:  EMBO Mol Med       Date:  2011-08-29       Impact factor: 12.137

View more
  28 in total

1.  Central Nervous System Delivery and Biodistribution Analysis of an Antibody-Enzyme Fusion for the Treatment of Lafora Disease.

Authors:  Grant L Austin; Zoe R Simmons; Jack E Klier; Alberto Rondon; Brad L Hodges; Robert Shaffer; Nadine M Aziz; Tracy R McKnight; James R Pauly; Dustin D Armstrong; Craig W Vander Kooi; Matthew S Gentry
Journal:  Mol Pharm       Date:  2019-08-02       Impact factor: 4.939

Review 2.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

Review 3.  Structural biology of glucan phosphatases from humans to plants.

Authors:  Matthew S Gentry; M Kathryn Brewer; Craig W Vander Kooi
Journal:  Curr Opin Struct Biol       Date:  2016-08-04       Impact factor: 6.809

Review 4.  Remarkable evolutionary relatedness among the enzymes and proteins from the α-amylase family.

Authors:  Štefan Janeček; Marek Gabriško
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

5.  Genes located in a chromosomal inversion are correlated with territorial song in white-throated sparrows.

Authors:  W M Zinzow-Kramer; B M Horton; C D McKee; J M Michaud; G K Tharp; J W Thomas; E M Tuttle; S Yi; D L Maney
Journal:  Genes Brain Behav       Date:  2015-10-14       Impact factor: 3.449

Review 6.  Lafora disease offers a unique window into neuronal glycogen metabolism.

Authors:  Matthew S Gentry; Joan J Guinovart; Berge A Minassian; Peter J Roach; Jose M Serratosa
Journal:  J Biol Chem       Date:  2018-02-26       Impact factor: 5.157

Review 7.  Lafora disease: from genotype to phenotype.

Authors:  Rashmi Parihar; Anupama Rai; Subramaniam Ganesh
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

8.  Polyglucosan body structure in Lafora disease.

Authors:  M Kathryn Brewer; Jean-Luc Putaux; Alberto Rondon; Annette Uittenbogaard; Mitchell A Sullivan; Matthew S Gentry
Journal:  Carbohydr Polym       Date:  2020-04-14       Impact factor: 9.381

Review 9.  Lafora disease - from pathogenesis to treatment strategies.

Authors:  Felix Nitschke; Saija J Ahonen; Silvia Nitschke; Sharmistha Mitra; Berge A Minassian
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

Review 10.  Structural mechanisms of plant glucan phosphatases in starch metabolism.

Authors:  David A Meekins; Craig W Vander Kooi; Matthew S Gentry
Journal:  FEBS J       Date:  2016-03-28       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.